The Quantellect read.As of Nov 19, 2026, 7 active firms cover HIVE Digital Technologies Ltd: 6 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets range widely, $4.60 to $10.00 (about 2.2x), a sign of real disagreement on valuation. The average target of $6.87 sits 391% above the current $1.40. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.10 next quarter toward $0.10 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 active firms
Buy
Strong Buy00%
Buy686%
Neutral114%
Sell00%
Strong Sell00%
Based on 7 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$6.87
+390.8% upside
Average target across 7 active firms as of Nov 19, 2026 vs $1.40 current
Highest Target$10.00
Average Target$6.87
Lowest Target$4.60
Detailed analyst forecasts for HIVE
Showing 1–8 of 8 named analysts shown · 7 active firms in the rating projection
As of Nov 19, 2026, 6 of 7 active firms rate HIVE a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
HIVE EPS & revenue forecast
EPS · NEXT QUARTER
$-0.10
Range $-0.10 – $-0.10 · 1 analysts
Next period, 1 analysts expect HIVE Digital Technologies Ltd to earn $-0.10 a share (range $-0.10 – $-0.10), versus — a year earlier. Full-year consensus is $-0.09, growing to $0.10 the year after.
REVENUE · NEXT QUARTER
$104.3M
Range $80.4M – $121.7M · 1 analysts · +45% YoY
Revenue is expected to reach $104.3M (range $80.4M – $121.7M), +45.3% year-over-year. Full-year consensus is $354.6M, rising to $486.4M next year.
Top analysts covering HIVE Digital Technologies Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HIVE.
#1
MC
Mike Colonnese
HC Wainwright & Co. · Rank #366
Buy
$7.00+400.0% to target
Overall win rate
35%
+ Follow
#2
NG
Nick Giles
B. Riley Securities · Rank #429
Buy
$5.00+257.1% to target
Overall win rate
34%
+ Follow
#3
CB
Chris Brendler
Rosenblatt · Rank #509
Buy
$6.00+328.6% to target
Overall win rate
31%
+ Follow
#4
Darren Aftahi
Roth Capital · Rank #523
Buy
$8.00+471.4% to target
Overall win rate
22%
+ Follow
#5
Brett Knoblauch
Cantor Fitzgerald · Rank #547
Buy
$7.00+400.0% to target
Overall win rate
28%
+ Follow
HIVE stock forecast FAQ
What is HIVE's average 12-month price target?+
The 7 active firms with a live target average $6.87 for HIVE Digital Technologies Ltd over the next 12 months, ranging from a $10.00 high to a $4.60 low, as of Nov 19, 2026.
Is HIVE stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 7 active firms as of Nov 19, 2026, 6 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for HIVE?+
The Street-high target is $10.00 (Canaccord Genuity), and the Street-low is $4.60 (Cantor Fitzgerald). The average of all 7 active-firm targets is $6.87.
How many active Wall Street firms cover HIVE?+
7 active firms have a recognized rating on HIVE Digital Technologies Ltd as of Nov 19, 2026, and 7 active firms carry a live 12-month price target.
Who is the most accurate analyst covering HIVE?+
Among analysts who currently cover HIVE, Mike Colonnese of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #366). Their current call is Buy with a $7.00 target.
What is HIVE Digital Technologies Ltd's projected EPS for next quarter?+
The consensus estimate is $-0.10 per share (range $-0.10 – $-0.10) across 1 analysts. Full-year EPS is projected at $-0.09, rising to $0.10 the following year.
How much revenue is HIVE Digital Technologies Ltd expected to report next quarter?+
Consensus revenue is $104.3M (range $80.4M – $121.7M). Full-year revenue is projected at $354.6M, growing to $486.4M next year.
Have analysts been upgrading or downgrading HIVE lately?+
As of Nov 19, 2026, 6 of 7 active firms rate HIVE a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HIVE calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.